Rezultati - Francesca Yates

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study od Peter Hillmen, Andy C. Rawstron, Kristian Brock, S Munoz-Vicente, Francesca Yates, Rebecca Bishop, Rebecca H. Boucher, Donald Macdonald, Chris Fegan, Alison M. McCaig, Anna Schuh, Andrew R. Pettitt, John G. Gribben, Piers Patten, Stephen Devereux, Adrian Bloor, Christopher P. Fox, Francesco Forconi, Talha Munir